Clinical trials with cannabis medicines—guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience

With cannabis medicines now obtaining legal status in many international jurisdictions (generally on the authorisation of a medical professional), a rapid increase in consumer demand for access to cannabis as a therapeutic option in the treatment and management of a range of indications is being not...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Jennifer H., Hill, Courtney, Walsh, Anna, Efron, Daryl, Taylor, Kaitlyn, Kennedy, Michael, Galettis, Rachel, Lightfoot, Paul, Hanson, Julie, Irving, Helen, Agar, Meera, Lacey, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673085/
https://www.ncbi.nlm.nih.gov/pubmed/33203469
http://dx.doi.org/10.1186/s13063-020-04862-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673085/
https://www.ncbi.nlm.nih.gov/pubmed/33203469
http://dx.doi.org/10.1186/s13063-020-04862-6

Ejemplares similares